
Elisa M. Rice
Examiner (ID: 18639, Phone: (571)270-1582 , Office: P/2669 )
| Most Active Art Unit | 2669 |
| Art Unit(s) | 2669, 2624 |
| Total Applications | 370 |
| Issued Applications | 269 |
| Pending Applications | 9 |
| Abandoned Applications | 94 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10782852
[patent_doc_number] => 20160129008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'Solid Dosage Form of Olmesartan Medoxomil and Amlodipine'
[patent_app_type] => utility
[patent_app_number] => 14/734893
[patent_app_country] => US
[patent_app_date] => 2015-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6543
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14734893
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/734893 | Solid Dosage Form of Olmesartan Medoxomil and Amlodipine | Jun 8, 2015 | Abandoned |
Array
(
[id] => 10174869
[patent_doc_number] => 09205056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Controlled release hydrocodone formulations'
[patent_app_type] => utility
[patent_app_number] => 14/728023
[patent_app_country] => US
[patent_app_date] => 2015-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12987
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14728023
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/728023 | Controlled release hydrocodone formulations | Jun 1, 2015 | Issued |
Array
(
[id] => 10380529
[patent_doc_number] => 20150265537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'CONTROLLED RELEASE HYDROCODONE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/727985
[patent_app_country] => US
[patent_app_date] => 2015-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12691
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14727985
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/727985 | Controlled release hydrocodone formulations | Jun 1, 2015 | Issued |
Array
(
[id] => 11310060
[patent_doc_number] => 20160346171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'ORAL COMPOSITION AND CONFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/724746
[patent_app_country] => US
[patent_app_date] => 2015-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11474
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14724746
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/724746 | ORAL COMPOSITION AND CONFECTION | May 27, 2015 | Abandoned |
Array
(
[id] => 10467112
[patent_doc_number] => 20150352127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'INHALATION PARTICLES COMPRISING A COMBINATION OF AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC'
[patent_app_type] => utility
[patent_app_number] => 14/724056
[patent_app_country] => US
[patent_app_date] => 2015-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9167
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14724056
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/724056 | Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic | May 27, 2015 | Issued |
Array
(
[id] => 11289280
[patent_doc_number] => 20160339213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'METHOD AND SYSTEM FOR SECLUDING A BODY VESSEL'
[patent_app_type] => utility
[patent_app_number] => 14/718865
[patent_app_country] => US
[patent_app_date] => 2015-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3378
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14718865
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/718865 | METHOD AND SYSTEM FOR SECLUDING A BODY VESSEL | May 20, 2015 | Abandoned |
Array
(
[id] => 10360988
[patent_doc_number] => 20150245993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'MATRIX CARRIER COMPOSITIONS, METHODS AND USES'
[patent_app_type] => utility
[patent_app_number] => 14/715585
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20822
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14715585
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/715585 | Matrix carrier compositions, methods and uses | May 17, 2015 | Issued |
Array
(
[id] => 10435671
[patent_doc_number] => 20150320682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'NANOPARTICULATE MEGESTROL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/713336
[patent_app_country] => US
[patent_app_date] => 2015-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21525
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14713336
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/713336 | NANOPARTICULATE MEGESTROL FORMULATIONS | May 14, 2015 | Abandoned |
Array
(
[id] => 11783553
[patent_doc_number] => 09392795
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-19
[patent_title] => 'Titanium dioxide photocatalytic compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/713020
[patent_app_country] => US
[patent_app_date] => 2015-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 6369
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14713020
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/713020 | Titanium dioxide photocatalytic compositions and uses thereof | May 14, 2015 | Issued |
Array
(
[id] => 10353450
[patent_doc_number] => 20150238455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/709937
[patent_app_country] => US
[patent_app_date] => 2015-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16223
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709937
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/709937 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME | May 11, 2015 | Abandoned |
Array
(
[id] => 13248939
[patent_doc_number] => 10137141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Treatment regimen tiacumicin compound
[patent_app_type] => utility
[patent_app_number] => 15/309992
[patent_app_country] => US
[patent_app_date] => 2015-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 8587
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309992
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/309992 | Treatment regimen tiacumicin compound | May 10, 2015 | Issued |
Array
(
[id] => 10353361
[patent_doc_number] => 20150238366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'Hemostatic Bioabsorbable Device with Polyethylene Glycol Binder'
[patent_app_type] => utility
[patent_app_number] => 14/707559
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5680
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707559
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707559 | Hemostatic bioabsorbable device with polyethylene glycol binder | May 7, 2015 | Issued |
Array
(
[id] => 10566242
[patent_doc_number] => 09289391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => 'Controlled release hydrocodone formulations'
[patent_app_type] => utility
[patent_app_number] => 14/706699
[patent_app_country] => US
[patent_app_date] => 2015-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12988
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14706699
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/706699 | Controlled release hydrocodone formulations | May 6, 2015 | Issued |
Array
(
[id] => 14516291
[patent_doc_number] => 10335379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Oral dosage forms of ketamine
[patent_app_type] => utility
[patent_app_number] => 15/304613
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 9103
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 317
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304613
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304613 | Oral dosage forms of ketamine | Apr 15, 2015 | Issued |
Array
(
[id] => 10379919
[patent_doc_number] => 20150264926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'Corrosive Ingredient(s)-Containing Compositions Having Reduced Toxicity And Method Of Obtaining'
[patent_app_type] => utility
[patent_app_number] => 14/666562
[patent_app_country] => US
[patent_app_date] => 2015-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6180
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14666562
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/666562 | Corrosive ingredient(s)-containing compositions having reduced toxicity and method of obtaining | Mar 23, 2015 | Issued |
Array
(
[id] => 10380733
[patent_doc_number] => 20150265741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'WOUND MANAGEMENT SYSTEM AND METHODS OF USING'
[patent_app_type] => utility
[patent_app_number] => 14/664264
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4354
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664264
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664264 | Wound management system and methods of using | Mar 19, 2015 | Issued |
Array
(
[id] => 10705435
[patent_doc_number] => 20160051582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CHRONIC PAIN'
[patent_app_type] => utility
[patent_app_number] => 14/659608
[patent_app_country] => US
[patent_app_date] => 2015-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14659608
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/659608 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CHRONIC PAIN | Mar 15, 2015 | Abandoned |
Array
(
[id] => 10774610
[patent_doc_number] => 20160120766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'COLLOIDAL FACIAL MASK WITH PARTIAL CARRIER AND METHOD FOR MANUFACTURING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/656325
[patent_app_country] => US
[patent_app_date] => 2015-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5474
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14656325
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/656325 | Colloidal facial mask with partial carrier and method for manufacturing the same | Mar 11, 2015 | Issued |
Array
(
[id] => 10634583
[patent_doc_number] => 09352070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-31
[patent_title] => 'Tissue prostheses for repairing, reconstructing and replacing damaged or diseased biological structures and associated tissue'
[patent_app_type] => utility
[patent_app_number] => 14/635118
[patent_app_country] => US
[patent_app_date] => 2015-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 8
[patent_no_of_words] => 8131
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14635118
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/635118 | Tissue prostheses for repairing, reconstructing and replacing damaged or diseased biological structures and associated tissue | Mar 1, 2015 | Issued |
Array
(
[id] => 10279850
[patent_doc_number] => 20150164846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'Microemulsion Topical Delivery Platform'
[patent_app_type] => utility
[patent_app_number] => 14/630073
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17015
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630073
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/630073 | Microemulsion topical delivery platform | Feb 23, 2015 | Issued |